ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
1-Year Return
45.88%
This Quarter Return
+20.56%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$84.3M
AUM Growth
+$12.6M
(+18%)
Cap. Flow
+$2.23M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
61.92%
Holding
37
New
10
Increased
7
Reduced
11
Closed
9
Top Buys
| 1 |
Medtronic
MDT
|
$5.77M |
| 2 |
Gilead Sciences
GILD
|
$4.05M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.58M |
| 4 |
Acadia Healthcare
ACHC
|
$3.49M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.73M |
Top Sells
| 1 |
HMSY
HMS Holdings Corp.
HMSY
|
$4.84M |
| 2 |
Eli Lilly
LLY
|
$4.51M |
| 3 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$3.2M |
| 4 |
Amicus Therapeutics
FOLD
|
$2.35M |
| 5 |
GSK
GSK
|
$2M |
Sector Composition
| 1 | Healthcare | 98.41% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRS
26
DELISTED
Antares Pharma, Inc.
ATRS
| $643K | 0.76% |
+199,655
| New | +$643K |
|
27
Regenxbio
RGNX
$469M
| $275K | 0.33% |
13,906
+1,508
| +12% | +$29.8K |
|
|
OXFD
28
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $273K | 0.32% |
+16,212
| New | +$273K |
|
29
AstraZeneca
AZN
$254B
| – | – |
-24,809
| Closed | -$773K |
|
30
Biogen
BIIB
$20.3B
| – | – |
-3,073
| Closed | -$840K |
|
31
Cardinal Health
CAH
$35.5B
| – | – |
-10,049
| Closed | -$819K |
|
32
Incyte
INCY
$16.8B
| – | – |
-12,931
| Closed | -$1.73M |
|
|
33
Eli Lilly
LLY
$664B
| – | – |
-53,583
| Closed | -$4.51M |
|
34
Puma Biotechnology
PBYI
$252M
| – | – |
-42,524
| Closed | -$1.58M |
|
35
Syndax Pharmaceuticals
SNDX
$1.37B
| – | – |
-60,087
| Closed | -$824K |
|
|
HMSY
36
DELISTED
HMS Holdings Corp.
HMSY
| – | – |
-237,802
| Closed | -$4.84M |
|
|
KERX
37
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| – | – |
-68,381
| Closed | -$421K |
|